Diurnal variation of the human adipose transcriptome and the link to metabolic disease. by Loboda, Andrey et al.
UCLA
UCLA Previously Published Works
Title
Diurnal variation of the human adipose transcriptome and the link to metabolic disease.
Permalink
https://escholarship.org/uc/item/1p290115
Journal
BMC medical genomics, 2(1)
ISSN
1755-8794
Authors
Loboda, Andrey
Kraft, Walter K
Fine, Bernard
et al.
Publication Date
2009
DOI
10.1186/1755-8794-2-7
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
BioMed CentralBMC Medical Genomics
ssOpen AcceResearch article
Diurnal variation of the human adipose transcriptome and the link 
to metabolic disease
Andrey Loboda†1, Walter K Kraft†2, Bernard Fine1, Jeffrey Joseph3, 
Michael Nebozhyn1, Chunsheng Zhang1, Yudong He1, Xia Yang1, 
Christopher Wright1, Mark Morris1, Ira Chalikonda1, Mark Ferguson1, 
Valur Emilsson1, Amy Leonardson1, John Lamb1, Hongyue Dai1, 
Eric Schadt1, Howard E Greenberg2 and Pek Yee Lum*1
Address: 1Rosetta Inpharmatics, LLC (A wholly-owned subsidiary of Merck & Co., Inc.), 401 Terry Ave N., Seattle, WA 98109, USA, 2Thomas 
Jefferson University, Department of Pharmacology and Experimental Therapeutics, Philadelphia, PA 19107, USA and 3Thomas Jefferson 
University, Department of Anesthesiology, Philadelphia, PA 19107, USA
Email: Andrey Loboda - andrey_loboda@merck.com; Walter K Kraft - Walter.Kraft@jefferson.edu; Bernard Fine - bfine@mit.alum.edu; 
Jeffrey Joseph - Jeffrey.Joseph@Jefferson.edu; Michael Nebozhyn - michael_nebozhyn@merck.com; 
Chunsheng Zhang - chunsheng_zhang@merck.com; Yudong He - yudong_he@merck.com; Xia Yang - xia_yang@merck.com; 
Christopher Wright - christopher_wright2@merck.com; Mark Morris - mark_morris@merck.com; Ira Chalikonda - ira_chalikon@merck.com; 
Mark Ferguson - mark_ferguson@merck.com; Valur Emilsson - valur_emilsson@merck.com; Amy Leonardson - aleonardson@gmail.com; 
John Lamb - john_lamb3@merck.com; Hongyue Dai - hongyue_dai@merck.com; Eric Schadt - eric_schadt@merck.com; 
Howard E Greenberg - heg23@cornell.edu; Pek Yee Lum* - pek_lum@merck.com
* Corresponding author    †Equal contributors
Abstract
Background: Circadian (diurnal) rhythm is an integral part of the physiology of the body;
specifically, sleep, feeding behavior and metabolism are tightly linked to the light-dark cycle dictated
by earth's rotation.
Methods: The present study examines the effect of diurnal rhythm on gene expression in the
subcutaneous adipose tissue of overweight to mildly obese, healthy individuals. In this well-
controlled clinical study, adipose biopsies were taken in the morning, afternoon and evening from
individuals in three study arms: treatment with the weight loss drug sibutramine/fasted, placebo/fed
and placebo/fasted.
Results: The results indicated that diurnal rhythm was the most significant driver of gene
expression variation in the human adipose tissue, with at least 25% of the genes having had
significant changes in their expression levels during the course of the day. The mRNA expression
levels of core clock genes at a specific time of day were consistent across multiple subjects on
different days in all three arms, indicating robust diurnal regulation irrespective of potential
confounding factors. The genes essential for energy metabolism and tissue physiology were part of
the diurnal signature. We hypothesize that the diurnal transition of the expression of energy
metabolism genes reflects the shift in the adipose tissue from an energy-expending state in the
morning to an energy-storing state in the evening. Consistent with this hypothesis, the diurnal
transition was delayed by fasting and treatment with sibutramine. Finally, an in silico comparison of
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BMC Medical Genomics 2009, 2:7 http://www.biomedcentral.com/1755-8794/2/7the diurnal signature with data from the publicly-available Connectivity Map demonstrated a
significant association with transcripts that were repressed by mTOR inhibitors, suggesting a
possible link between mTOR signaling, diurnal gene expression and metabolic regulation.
Conclusion: Diurnal rhythm plays an important role in the physiology and regulation of energy
metabolism in the adipose tissue and should be considered in the selection of novel targets for the
treatment of obesity and other metabolic disorders.
Background
Circadian (diurnal) rhythms are part of the daily lives of
many living organisms, from photosynthetic prokaryotes
to higher eukaryotes [1,2]. These oscillations likely
evolved to ensure temporal coordination of physiological
and behavioral processes, both for adapting to predictable
daily environmental changes and orchestrating cellular
machinery necessary for life. For example, in cyanobacte-
ria and Arabidopsis, the circadian oscillator directs tran-
scription of the photosynthetic machinery to the daylight
hours, thereby ensuring the efficient assimilation of light
energy [3].
Although first described in the suprachiasmatic nucleus,
circadian clocks have been identified in many peripheral
tissues, including adipose, heart, kidney and vasculature
[4-6]. These peripheral clocks are regulated by central cir-
cadian clock machinery and circulating serum markers of
circadian function [7,8]. In animal models, many genes in
peripheral tissues show oscillatory behavior that is
responsive to restricted feeding or other perturbations [9].
The molecular mechanism of the circadian oscillator as a
transcriptional-translational feedback loop has been
unraveled by genetic analyses in Drosophila and mammals
[1]. Two transcriptional activators, CLOCK and MOP3/
BMAL1, and their target genes, including PER1, PER2,
PER3, CRY1, and CRY2, generate a circadian oscillation in
their own transcription. Although the core pacemaker
involves about a dozen genes, the number of genes that
exhibit oscillatory behavior (the circadian output genes)
may be much greater. For instance, more than half of the
yeast genome is expressed periodically during metabolic
cycles [2]. Circadian regulation of genes responsible for
basic energy metabolism has also been reported in mice
[4-6,10,11].
Alterations of circadian rhythms have been associated
with several disease states [8,12,13]. Several epidemiolog-
ical studies have demonstrated an increased incidence of
metabolic syndrome among night shift workers who have
chronically disrupted circadian rhythms [14,15]. Support-
ing evidence comes from CLOCK mutant mice, shown to
be hyperphagic and obese and to develop metabolic syn-
drome in addition to having a disrupted circadian rhythm
[16].
Many studies in animals and model systems on the effect
of circadian rhythm on gene transcription have been con-
ducted; however, diurnal effects on human tissues are
poorly characterized, likely owing to the difficulty associ-
ated with non-invasively collecting human tissue samples
multiple times/day. Rodent models, while useful, have
limitations due to their nocturnal habits and, therefore,
certain aspects of the circadian regulation would likely be
different from humans. The purpose of this controlled
clinical study was to examine the effect of diurnal rhythm
on gene expression in the subcutaneous adipose tissue of
overweight to mildly obese, healthy individuals and the
potential effect of fasting and the anti-obesity drug, sibu-
tramine. We show that remarkably, the expression levels
of the core clock genes and the diurnal output genes
showed little day-to-day variation during the duration of
the study, despite the adipose biopsies being taken from
multiple subjects in a trial that lasted over a period of
time. Rather, the time of day was the key driver of the
expression levels of both core clock and diurnal output
genes. We see that diurnal signature was large and con-
sisted of genes involved in growth factor signaling,
inflammation and ribosome processing and biogenesis.
We also report that both the core clock genes and diurnal
output genes were affected by fasting and sibutramine
albeit subtly. A connection between growth factors and
their inhibitors and adipose metabolism was also
observed, leading to the possibility of re-positioning com-
pounds developed for other indications to treat obesity or
other metabolic diseases.
Methods
Study population and design
Participants were overweight to moderately obese (BMI =
27 to 35 kg/m2), healthy, male volunteers, ages 21 to 45
years. Subjects with medical illness, smoking history (6
months prior to study start), history of keloids or bleeding
disorder, recent change in weight (+/- 4 kg), or use of pre-
scription medications or NSAIDS two weeks prior to study
start were excluded from the study.
This was a single-site, 3-period, randomized, placebo-con-
trolled, cross-over study (Figure 1). The night before
planned adipose biopsies, subjects were admitted to the
Phase 1 unit, where standardized meals identical in con-
tent and quantity were provided. After the standardizedPage 2 of 16
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6:30 am and 8:30 am the following morning, subjects
underwent a subcutaneous adipose biopsy procedure fol-
lowed by administration of a single oral dose of 30 mg (3
× 10 mg capsules) sibutramine or placebo. The placebo/
fed arm had breakfast 30 minutes post-dose. Between
12:30 pm and 2:30 pm (6 hours post-dose), all subjects
underwent a second subcutaneous adipose biopsy proce-
dure followed by a standardized lunch. Between 4:30 pm
and 6:30 pm (10 hours post-dose), all subjects underwent
a third subcutaneous adipose biopsy procedure. The same
subject in this crossover study received a total of 9 biop-
sies over the duration of the study, with 7 days between
visits. Careful recording of the timing of adipose biopsies,
food intake and sibutramine/placebo administration was
implemented and each participant had biopsies per-
formed by the same physician.
Schematic of study designFigure 1
Schematic of study design. The first biopsy procedure was performed at 6:30 am to 8:30 am, followed by two more biop-
sies: one in the afternoon (12:30 pm to 2:30 pm) and one in the evening (4:30 pm to 6:30 pm). The same subject in this cross-
over design received 9 biopsies over the study duration, with at least 7 days in between visits. In total, 153 adipose samples 
were obtained and hybridized (17 subjects × 3 time points × 3 periods).Page 3 of 16
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the Declaration of Helsinki, as reflected in approval by the
Institutional Review Board of Thomas Jefferson Univer-
sity.
Biopsy procedure
A small incision in the umbilical region was made to
introduce a large bore aspiration cannula (3 mm × 15 cm,
Bryon Medical, Tucson, AZ). The cannula was advanced
within the anesthetized quadrant while suction from a
syringe was maintained. After 1 mL of adipose was col-
lected, after ~6 passes, the cannula was withdrawn. A dif-
ferent quadrant was used each day for collection. The
cannula was introduced at each time point using the same
incision site. Adipose samples were flash frozen in liquid
nitrogen.
Globin RNA mitigation
To facilitate the collection of multiple human adipose
biopsies from a single subject, a minimally invasive
method using a syringe was used. Because the syringe
method resulted in variable blood contamination in the
adipose tissue, Ambion's (Austin, TX) GLOBINclear™ par-
amagnetic bead capture technology was used to deplete
the total RNA sample of globin mRNA, mitigating globin
RNA expression to minimize the potential effect of globin
contamination on the microarray hybridization.
Gene expression profiling
Overall, 153 adipose samples were obtained and hybrid-
ized (17 subjects × 3 time points × 3 periods). The adipose
collection technique was generally well tolerated. Two
subjects discontinued during the conduct of the study;
one of these subjects was replaced. In total, 17 subjects
completed the trial: 13 black, 5 white and 1 mixed race.
Evaluation of the globin mitigation technique in a subset
of samples demonstrated that the outcome was not mark-
edly different in processed versus non-processed samples,
except in smaller signatures, for which the GLOBINclear™
procedure improved the results (Additional files 1 and 2).
Data derived from both processed and non-processed
samples were used in this analysis.
Total RNA was isolated from the adipose tissues and con-
verted to fluorescently labeled cRNA that was hybridized
to Agilent oligonucleotide microarrays [17,18]. The adi-
pose microarray data from this study was deposited into
the GEO database under accession number GSE10545.
The human gene expression array pattern used was previ-
ously deposited in the GEO database (GPL3991).
Icelandic replication analysis
An independent study was examined to determine
whether a common feeding or fasting gene expression sig-
nature existed in human adipose tissue. Repeat (1 week
apart) biopsies of abdominal subcutaneous fat were iso-
lated from 20 healthy Icelandic subjects. All participants
had been fasted overnight (from 9:00 pm) and were ran-
domly assigned to one of two groups: A) The fasted group
(n = 10), in which the subject fasted throughout the
morning until noon, at which time subcutaneous adipose
tissue was collected, or B) The fasted/fed cross-over group
(n = 10), in which the subject participated in both a fast-
ing arm (as described in A) and a feeding arm in which the
subject consumed a meal between 9:00 am and 10:00 am
and subcutaneous adipose tissue was collected two hours
later (Additional file 3). Subcutaneous fat samples (5–10
cm3) were removed through a 3 cm incision at the bikini
line (always from the same site to avoid site-specific vari-
ation) after local anesthesia using 10 mL of lidocaine-
adrenalin (1%). The incision was closed using a 4/0 vicryl
intracutan suture. The adipose tissue samples were placed
into aluminum pouches and flash-frozen in liquid nitro-
gen. A 3 mL alloquot of TRI-Reagent (Molecular Research
Center, Inc., Cincinnati, OH) was added to a 600 ± 30 mg
piece of fat, and immediately homogenized using an
Omni PCR Tissue Homogenizing Kit (OMNI Interna-
tional, Warrenton, VA) for one minute.
Data analysis
Gene expression data were analyzed using Rosetta
Resolver gene expression analysis software (version 7.0,
Rosetta Biosoftware, Seattle, WA) and MATLAB (The
MathWorks, Natick, MA), following the methods and
algorithms developed at Rosetta Inpharmatics [19,20]. To
assess the effect of diurnal variation on gene expression
and derive a meaningful estimate of the number of genes
affected, accounting for the number of false positives due
to multiple testing, additional analyses were performed to
control for the false discovery rate (FDR; Additional file
4); i.e., the proportion of likely false positives, as previ-
ously described [21,22]. The diurnal effect on gene expres-
sion was analyzed with a 3-way ANOVA model (time ×
treatment × patient) via a Monte-Carlo simulation with
100 random permutations. Based on a p-value of 0.01 for
~5000 genes detected in non-permuted data, the expected
FDR as estimated by the q-value was ~5% for the mean
number of genes satisfying the alpha significance cut-off
of < 0.01 among 100 randomizations and the correspond-
ing 95th percentile. A separate analysis was conducted to
ensure the adequacy of 100 permutations to provide sta-
ble estimates relative to the number of randomizations
performed.
A variance filter was applied to remove the genes that
showed little to no variation across all experimental con-
ditions to reduce the false discovery rate associated with
multiple testing. The filter used was based on the Agilent
platform p-value as previously described [20]. 20,000
genes passed the filtering at p < 0.01 and were used forPage 4 of 16
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eset was identified using all the samples in the dataset
(Spearman correlation based p-value < 0.01). To compare
the gene expression changes related to diurnal rhythm in
the different treatment arms, three additional correlations
with the PER1 probe were obtained for each of the treat-
ment arms.
Gene function and pathway analysis was performed
through the use of Ingenuity Pathways Analysis (Ingenu-
ity® Systems). Canonical pathways analysis identified the
pathways that were most relevant to the data set. The sig-
nificance of the association between the data set and the
canonical pathway was measured as a ratio of the number
of genes from the data set that map to the pathway
divided by the total number of genes that map to the
canonical pathway. Additionally, Fisher's Exact test was
used to calculate a p-value to determine whether the asso-
ciation between the genes in the dataset and the canonical
pathway could be explained by chance alone. The signifi-
cance of the overlap between gene sets was also deter-
mined using Fisher's Exact test under the null hypothesis,
stating that the frequency of the signature genes is the
same between a reference set of 20,000 genes and the
comparison gene sets.
In silico experiment: correlation between the diurnal 
signature and the Connectivity Map
To characterize the physiology of diurnal changes in the
human adipose, an unbiased in silico search for com-
pound signatures common with diurnally regulated genes
identified in the present study was performed using the
publicly available Connectivity Map database [23]. The
Connectivity Map (also known as CMAP) is a collection of
genome-wide transcriptional data from cultured human
cells treated with different kinds of compounds. The top
200 correlated and 200 anti-correlated probes signifi-
cantly correlated to the PER1 probe (Spearman correla-
tion based p-value < 10e-15) were selected from the initial
PER1 geneset. The probes were then mapped to the
U133A probe sets in order to query the Connectivity Map
database. In total, 369 U133A probe sets mapped to the
selected probes from this study. The connectivity scores
and p-values were obtained using CMAP algorithm [23].
Results
Diurnally-regulated genes dominate the adipose tissue 
signature
The transcriptional program in the human adipose was
largely dominated by the diurnal effect. Figure 1 illustrates
a schematic of the study, where biopsies from 17 subjects
(BMI 27–35; Age 21–45) were taken in the morning, after-
noon and evening. Each subject was admitted to the Phase
1 clinical unit the evening before the start of the trial so
that food intake prior to the first biopsy can be properly
controlled. The subject then stayed in the clinic through-
out the day until all three biopsies were completed. Sub-
cutaneous adipose biopsies were taken around the
umbilical region (see Methods for details). This tight clin-
ical setup allowed us to control for variables that might
affect gene expression changes not due to the main pertur-
bations. The time of day and patient-to-patient variation
had the most profound effect on gene expression, inde-
pendent of day of biopsy or treatments. To evaluate which
factor had the greatest effect on the gene expression
observed in the adipose samples, we first performed
ANOVA analysis for patient, time and drug treatment on
each gene that passed a variance threshold. Among
20,000 genes that passed the variance criteria, 5,194 had
p-values < 0.01 for diurnal variation, 6,097 had p-values
< 0.01 for inter-patient variation, and 180 had p-values <
0.01 (q-value of ~5%) for treatment (See details in Meth-
ods and Additional files 4 and 5). The large but expected
inter-patient variability reflects the power of study and the
quality of the expression profiles. In addition to the uni-
variate analysis above, we also performed Principal Com-
ponent Analysis and found the first principal component
to be most significantly associated with time of day. Both
the univariate and multivariate analyses showed that time
of biopsy had a significant effect on gene expression with
approximately 5,000 transcripts regulated in a diurnal
fashion. Overall, the most profound changes occurred
from the morning to the afternoon and the gene expres-
sion changes were smaller from the afternoon to the
evening (Figure 2).
The circadian gene, PER1, was prominent among the
genes with significantly higher expression in the morning
versus the afternoon or evening, with up to a 10-fold
change in some patients for PER1 mRNA expression (Fig-
ure 3). Known clock genes, including CLOCK, CRY2,
BHLHB2 and others, were diurnally regulated in the
human adipose (Figure 3). Approximately 5,000 genes
were significantly correlated with PER1 mRNA levels
(Additional file 6). As expected, significant overlap was
observed between the diurnal output gene set from the
ANOVA analysis and the PER1 correlated gene set. Genes
that were positively correlated with PER1 mRNA levels
included those involved in fructose and mannose metab-
olism and glycolysis (PFKFB, FUK, MPI, PFKM) [4]. Con-
versely, such genes involved in inflammatory pathways as
the cytokines (IL6 and IL8), glucose transporters (GLUT1,
GLUT3, GLUT5, GLUT14), cholesterol biosynthesis genes
(HMGCR, HMGCS), the low density lipoprotein receptor
(LDLR) and genes that control response to free radicals
(HMOX1) and hypoxia (HIF1A) were significantly, but
negatively, correlated with PER1 mRNA. Transcripts that
were most strongly correlated to PER1 were ZNF145 (a
zinc finger transcription factor that regulates the renin/
prorenin receptor), METRS (involved in rRNA synthesis)Page 5 of 16
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Genes previously shown to be diurnally regulated, such as
SERPINE1 (PAI-1), were also negatively correlated to
PER1 mRNA expression in this dataset [27,28]. Pathways
that were enriched in the diurnal signature included
inflammatory pathways and the NFKb pathway. Supple-
mental literature mining processes (Ingenuity) showed
that IL-10, IL-6, p38MAPK and PPAR signaling pathways
were also enriched (Table 1 and Additional file 7). Tests
for biological pathway enrichment in the PER1 correlated
genes demonstrated high enrichment for genes involved
in RNA processing, ribosome biogenesis and splicing
(Table 2).
Genes regulated in the three states – fed, fasted and sibu-
tramine treated – were similarly affected by the diurnal
signal (Figure 4). In the assessment of diurnal regulation
by correlation to PER1, a high degree of correlation
among the three states was observed, indicating that the
largest effect on the transcriptome is the time of day and
not any other perturbations; nevertheless, there were
~500 genes with significantly different correlations to
PER1 among the three states.
Impact of food restriction on the transcriptional profile of 
the adipose tissue
Further investigation of genes that were differentially reg-
ulated between fasting and feeding at the 6 hour pre-meal
The impact of diurnal rhythm on global gene expression changes in all subjectsFigure 2
The impact of diurnal rhythm on global gene expression changes in all subjects. This heatmap illustrates that more 
than 5,000 genes were significantly associated with diurnal rhythm in the human adipose tissue over multiple days and subjects, 
irrespective of treatment arm. PER1 mRNA levels decreased and cytokine mRNA levels increased from the morning to the 
evening (red block arrows depict levels schematically). The y-axis lists the subjects ordered by time of biopsy and the x-axis 
lists diurnally regulated genes clustered hierarchically with the agglomerative clustering algorithm. The heatmap color scale is in 
log10, arranged from magenta (upregulated) to cyan (downregulated).Page 6 of 16
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tially expressed between the fasted and fed arms (p <
0.01); 318 genes had higher correlations and 180 had
lower correlations in the fasted arm compared with the
fed arm (Figure 5). Despite the small difference between
the fasted and fed arms, the association with the diurnal
signature as measured by PER1 correlation was significant
(Figure 5). Overall, 94% of the genes with expression lev-
els affected by food intake were correlated to PER1 expres-
sion (p < 0.01). In addition, genes that were upregulated
in the fasting arm were positively correlated with PER1
expression and genes that were upregulated in the fed arm
were negatively correlated with PER1. Because these signa-
ture genes were also correlated with PER1, the fasting arm
positively affected the genes that were on the diurnal
decline (levels trending downward from morning
through evening), whereas the fed arm positively affected
the genes that were on the diurnal incline (levels trending
upward from morning through evening) (Figure 5).
Genes that were differentially regulated between the
fasted and fed treatment arms at the 6 hour timepoint
continued to be regulated at the 10 hour time point in the
fasted arm, but not in the fed arm (Figure 6).
Several genes that were regulated by fasting in this study
formed a highly connected node in the Ingenuity net-
work, indicating that these genes have been found to be
biologically inter-connected in other independent studies.
In this tight network, the gene oncostatin (OSM), a mac-
rophage-expressed gene [26], was downregulated > 2-fold
in the fasted state compared with the fed state. Forming a
network with OSM are other genes that are also downreg-
ulated by fasting, such as LDLR, MMP3, EGR1 and IL8.
Although the inflammatory genes overall were on the
incline with the diurnal rhythm, the inflammatory genes
were more downregulated in the fasted state, suggesting
that fasting delays the diurnal rhythm by dampening the
upward climb of the expression of these inflammatory
genes.
Icelandic replication analysis
With the aim of validating the fasting and feeding signa-
tures of the present study, we analyzed another com-
pletely independent study carried out on 20 Icelandic
subjects (see Methods and Additional file 3 for details).
There was a significant overlap of ~9% of the fasting sig-
natures observed in 20 Icelandic subjects compared with
the signatures observed in the current study (p = 1.77 × 10-
11), despite potential confounding factors such as a
slightly different experimental paradigm, ethnicity and
population bias. LDLR, a gene in the aforementioned
OSM (Oncostatin) network, was among the genes com-
mon between these two datasets.
Impact of the anti-obesity drug, sibutramine, on the 
transcriptional profile of the human adipose tissue
At 6 hours post-dose (afternoon), 136 genes had differen-
tial expression between sibutramine and placebo in the
fasted state (p-value < 0.01 by ANOVA), fewer than the
200 genes expected by random chance. At 10 hours post-
dose (early evening), 552 genes had differential expres-
sion between sibutramine and placebo in the fasted state
(p-value < 0.01 by ANOVA). The genes upregulated in the
drug treatment arm were positively correlated with PER1
and the downregulated genes were negatively correlated
with PER1 (Figure 7), a pattern very similar to what we
Table 1: Top biological enrichments for the diurnal signature 
correlated genes
Similar Set Expectation
response to wounding 3E-19
inflammatory response 9E-16
multi-organism process 3E-14
locomotory behavior 4E-13
taxis 4E-13
chemotaxis 4E-13
response to bacterium 6E-12
response to other organism 6E-12
cytokine-cytokine receptor interaction 2E-10
response to biotic stimulus 4E-10
behavior 2E-09
leukocyte migration 7E-07
blood vessel development 2E-06
vasculature development 2E-06
cell activation 2E-06
leukocyte chemotaxis 3E-06
blood vessel morphogenesis 3E-06
Expectation: p-value after Bonferroni adjustment
Table 2: Top biological enrichments for PER1 correlated genes.
Similar Set Expectation
RNA processing 1E-10
ribosome biogenesis and assembly 4E-06
rRNA processing 6E-06
rRNA metabolic process 9E-06
ribonucleoprotein complex biogenesis and assembly 8E-05
RNA splicing 1E-03
IL1 signaling pathway 2E-03
anti-apoptosis 4E-03
I-kappaB kinase/NF-kappaB cascade 7E-03
response to biotic stimulus 9E-03
negative regulation of apoptosis 1E-02
mRNA metabolic process 1E-02
negative regulation of programmed cell death 1E-02
blood vessel morphogenesis 2E-02
response to virus 2E-02
regulation of cell cycle 2E-02
IL-6 signaling 3E-02
mRNA processing 3E-02
Expectation: p-value after Bonferroni adjustmentPage 7 of 16
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differential signature between the placebo arm ("fasted
arm") and the drug arm only at the last time point. We
note that the subjects would have been fed once 4 hours
before the 10 hr time point biopsy (Figure 1). By this time,
the fasted arm may have already "caught up" with the fed
arm as we do not find any differentially expressed genes
between the fasting and fed groups at the 10 hr time point,
whereas that difference between those two arms existed at
the 6 hr time point. We did, however, find a significant
number of differentially regulated genes between sibu-
tramine and placebo at 10 hr, indicating that sibutramine
was still actively affecting the diurnal genes and the phase
shift is allowing the sibutramine – placebo groups to be
different. As shown in Figure 7, these genes are still corre-
lated to PER1 mRNA levels. There was no significance dif-
ference between the placebo (fasted) and the sibutramine
at the 6 hr time point because they were both equally
affecting the diurnal genes in the fasted state.
Inhibitors of Growth Factor Pathways "reverse" the diurnal 
signature in silico
In order to investigate what other perturbations will result
in similar transcriptional changes to those we observed in
the adipose brought on by the diurnal rhythm, we per-
formed an in silico experiment, leveraging the publicly
available data in the Connectivity Map [23] which con-
tains a collection of signatures elicited by treatment of
human cell lines with high doses of many different drugs
for 6 hours. The diurnal signature showed the most signif-
Temporal profiles of gene expression changes for several core circadian genes [50]Figure 3
Temporal profiles of gene expression changes for several core circadian genes [50]. Each panel illustrates the mean 
gene expression level (± standard error) across the cohort of patients at 8 am, 2 pm, and 6 pm by treatment arm. The genes 
are grouped into panels by their temporal profiles and/or similar biological functions. The top left panel shows profiles for 
PER1, PER2, and PER3 genes. The p-value for time-dependent change is determined by two-way ANOVA for time and patient. 
Although all three genes show time-dependent changes and consistently have high levels in the morning and low levels in the 
afternoon across three periods, change in PER1 has the largest amplitude and significance among all core circadian genes. 
NR1D1 and NR1D2, shown in the bottom left panel, have downward trends, especially from 2 to 6 pm. The genes shown in 
the top right panel have relatively small temporal changes characterized by a dip at 2 pm, relative to 8 am and 6 pm measure-
ments. The genes in the bottom right panel have a robust upward trend.Page 8 of 16
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elicited by drugs that block the PI3K-mTOR pathways
such as sirolimus (also known as rapamycin), LY-294002
(selective phosphatidylinositol 3-kinase (PI3K) inhibi-
tor), and wortmanin (also a phosphatidylinositol 3-
kinase (PI3K) inhibitor) (Table 3). Sirolimus was also the
top hit when the Connectivity Map was queried using the
PER1 signature (Additional file 8).
Discussion
The adipose tissue, a major player in energy homeostasis
in the body, has a complex mechanism of metabolism
regulation, controlled both by internal rhythm and exter-
nal stimuli, such as food intake. The effect of the circadian
rhythm on the transcriptome of the adipose and liver has
been described in animal models; however, studies exam-
ining diurnal or fasting effects or the effect of anti-obesity
drugs on the transcriptome in the human adipose tissue
are lacking.
The present study shows that the diurnal effect dominates
the transcriptome of the human adipose tissue, with more
than 25% of the transcribed genes being diurnally regu-
lated. This finding is consistent with observed circadian
regulation in adipose in animal models, in which up to
50% of the genes are under circadian control [5,7,11].
Moreover, the results demonstrated robust regulation of
the core clock gene PER1 and of genes encoding for ribos-
ome processing and biogenesis and inflammatory proc-
esses. Ribosome biogenesis genes were on the diurnal
incline, with levels rising by afternoon and remaining
constant until evening. Ribosome biogenesis is an indica-
tor of cellular activity and, in this case, most likely driven
by the AKT/PI3K/mTOR pathway [29]. A number of genes
encode enzymes in glucose, mannose and fructose metab-
olism (PFKFB3, FUK, MPI, PFKM), with high expression
levels in the morning and a decline in the afternoon
through the evening, following the trend of PER1. Con-
versely, "fuel accumulation" genes, such as those involved
in cholesterol biosynthesis (HMGCR, HMGSC1), LDL
receptor (LDLR), and glucose transport (GLUTS 1, 3, 5
and 14) have low levels in the morning and rise in the
afternoon. Interestingly, there was no observed correla-
tion between the more typical lipogenesis or transporter
genes, such as fatty acid synthase (FASN) or GLUTs 2 and
4, and PER1 expression. These genes may be regulated in
a more acute fashion by external stimulation, such as
insulin or cholesterol, or may not be sensitive to diurnal
regulation in the adipose tissue of mildly obese subjects.
Many genes encoding for cytokines and other inflamma-
tion-related proteins were also diurnally regulated. The
mRNA levels of this set of genes were inversely correlated
with PER1 expression, with expression levels increasing
dramatically from the morning through the afternoon
and being highest in the evening. These genes had among
The majority of the genes in the three states, fed, fasted and sibutramine-treated, were similarly affected by the diurnal signalFigure 4
The majority of the genes in the three states, fed, fasted and sibutramine-treated, were similarly affected by 
the diurnal signal. Correlations to PER1 in the three states were very high (blue dots), indicating that the diurnal effect over-
whelmed the rest of the perturbations. However, a small number of genes had correlations to PER1 that were significantly dif-
ferent between the states (green dots). The correlation plots are slightly tilted off the diagonal.Page 9 of 16
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20-fold (IL-6). Whereas studies have previously shown
that inflammation-related proteins, such as PAI-1, IL-6
and TNFα, were diurnally regulated [12,28], the present
result adds several new cytokines, including PTX3, IL1,
IL10, GRO1, GRO2, CCL6, TGFA and CCL7 to the set of
known diurnally regulated genes. Many cytokines, such as
IL-6 and IL-8 and MCP-1, have been implicated in cardio-
vascular risk; the present study demonstrated that both IL-
6 and IL-8 were significantly, but inversely, correlated
with PER1. The observed associations between these pro-
inflammatory genes with the diurnal rhythm warrant fur-
ther investigation.
To further characterize the physiology of the diurnal
change in the human adipose, an unbiased in silico search
for compound signatures common with the diurnally reg-
ulated genes in our study was performed using the pub-
licly available Connectivity Map database. Significant
overlap was observed with the AKT/PI3K/mTOR pathway
inhibitors, leading to the hypothesis that a signature elic-
ited by insulin or other growth factors would also overlap
with the diurnal signature. To test this hypothesis, we used
a set of genes that were regulated by treatment of growth
factors such as EGF, b-FGF, IGF1, Insulin or Heregulin in
MCF7 and HT29 cell lines (Additional file 9; manuscript
submitted). As expected, the growth factor pathway genes
were correlated with PER1 and the correlations were in the
same direction as that of the diurnal set. Moreover, the
Genes with expression levels that were changed by fasting and feeding were also diurnally regulatedFigure 5
Genes with expression levels that were changed by fasting and feeding were also diurnally regulated. A) In gen-
eral, genes in the fasting signature were positively correlated with PER1 whereas genes in the feeding signature were negatively 
correlated with PER1. B) These two heatmaps show the trend of these signatures throughout the day. Morning, afternoon and 
evenings are separated by yellow dotted lines. The color scale of the heatmaps is the same as in Figure 2A. A solid red arrow 
depicts PER1 mRNA levels declining over time. C) The proposed phase differences produced by fasting and feeding.Page 10 of 16
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tors from the Connectivity Map query.
The connection between the AKT/PI3K/mTOR pathway
and the diurnally regulated adipose tissue is intriguing.
Several studies have linked the AKT/PI3K/mTOR pathway
to obesity and, independently, the circadian rhythm to
metabolic syndrome [16,30,31]. A key kinase in the
mTOR pathway is S6K. The S6K -/- mouse is resistant to
diet-induced obesity, having adipocytes that do not accu-
mulate lipids [30]. The mTOR pathway is strongly upreg-
ulated during adipogenesis [31,32]. The CLOCK mutant
mouse has metabolic syndrome [16]. Regulated by AKT
and a key player in the AKT/PI3K/mTOR pathway, glyco-
gen synthase kinase 3 beta (GSK-3), the critical check-
point for glycogen synthesis, is linked to the circadian
rhythm [33]. Modulation of GSK-3, also known as shaggy,
alters circadian rhythms in Drosophila and affects clock
genes in mammalian cells [34,35]. The findings of the
present study are consistent with the connection between
the mTOR pathway and the link between circadian
rhythm and glucose metabolism. Several cancer drugs that
target growth factor pathways might "reverse" the circa-
dian pattern, thus preventing adipose from going into
lipid accumulating/anabolic state in the evening. This
hypothesis is consistent with the reported side effects of
sirolimus, a drug with a significant negative association
with circadian rhythm and that leads to hyperlipidemia
and accumulation of fatty acids in circulation [36,37],
possibly owing to the very high doses necessary, which
may prevent the anabolic state of the adipose. Data from
various F2 mouse crosses also show that mTOR is causal
for obesity traits [38]. Taken together, these observations
Genes that were differentially regulated between fasting and feeding at the 6 hour time point continue to be regulated at the 10 hour time point for th  fasted arm, but no  for the fed armFigure 6
Genes that were differentially regulated between fasting and feeding at the 6 hour time point continue to be 
regulated at the 10 hour time point for the fasted arm, but not for the fed arm. The left panels show that the 6 
hour to 10 hour changes for the fast-fed signature in the fed arm mostly center around zero; the right panels show significant 
changes for the fast-fed signature in the fasted arm. Subjects in all arms were fed 30 minutes after the 6 hour biopsy time point. 
Y-axis: number of genes. X-axis: Fold changes (log10) between 6 hour and 10 hour time points.Page 11 of 16
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be useful anti-obesity compounds.
Consistent with the observations on the tissue level, the
addition of glucose to a rodent cell line led to the down
regulation of PER1 and induction of circadian oscillations
[39]. In the same model system, oscillations have been
induced by the addition of growth factors or prolonged
activation of MAPK pathway, and stalled by MEK inhibi-
tors [40]. In addition, BMAL and CLOCK have involve-
ment in glucose homeostasis [41]. These results, together
with the findings from the present study, provide support
for an association of circadian rhythm with growth factor
signaling and metabolic effects.
Another interesting compound uncovered by the in silico
query of the Connectivity Map was resveratrol, a natural
activator of SIRT1 – a circadian deacetylase for core clock
components, countering the effect of CLOCK, shown to
have histone acetylation activity [42,43]. SIRT1 is also
linked to metabolic disease [44]. This result provides
additional support for the link between diurnal rhythm
Differentially regulated genes between the sibutramine treated arm and the fasted arm (both arms started the procedure in a fast d state) at the 10 hour tim  pointFigu  7
Differentially regulated genes between the sibutramine treated arm and the fasted arm (both arms started 
the procedure in a fasted state) at the 10 hour time point. The top panel shows the correlations to PER1 of genes that 
are upregulated by sibutramine. The bottom panel shows the correlations to PER1 of genes that are downregulated by sibu-
tramine. The red dotted line marks the zero point. Y-axis: number of genes. X-axis: correlations to PER1.Page 12 of 16
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clearly overlapped (p = 1.16 × 10-13) with a large set of key
genes that form an adipose module in a gene-gene corre-
lation network that tested causal for various metabolic
endpoints, such as obesity, diabetes and cardiovascular
disease [45]. This underscores that genes in the adipose
diurnal signature can be mined for drug targets against
obesity and other metabolic phenotypes. One of the most
correlated PER1 genes in the adipose was ZNF145 (also
known as PLZF), which drives metabolic syndrome in rats
and affects the transcription of the prorenin/renin recep-
tor [24,46]. A recently implicated gene in humans for
obesity, FTO, is also part of the PER1 signature [47].
The physiological changes associated with the diurnal var-
iation of the human adipose transcriptome are important
to understand. It is reasonable that humans, like other
organisms that live according to the light-dark cycle
imposed by earth's rotation, would evolve to compart-
mentalize energy metabolism in synchrony with diurnal
rhythm. We hypothesize that diurnal rhythm in human
adipose underlies the transition from a catabolic, energy-
releasing state in the morning to an anabolic, energy-stor-
ing state in the evening.
A phase shift in circadian rhythm induced by restricted
feeding has been reported in animal studies [5]. Similarly,
the present study showed that both the fasting state and
sibutramine were part of the diurnal signature, indicating
that these two perturbations had an effect on the metabo-
lism of the adipose tissue. Both interventions induced a
temporal delay in the diurnal rhythm, thereby extending
the catabolic state of the adipose (into the afternoon with
fasting and into the evening with sibutramine). The delay
observed in the fasting arm ended by the evening, likely
owing to the fact that subjects were fed in the afternoon.
However, the delay caused by sibutramine was evident at
the last time point, even after feeding, indicating that sib-
utramine was still actively affecting the diurnal genes. One
of the most differentially down regulated genes in the sib-
utramine versus the fasted arm at the 10 hour time point
was chemokine (C-X-C motif) ligand 1 (CXCL1), a
secreted cytokine involved in numerous inflammatory
pathways. CXCL1 is also known as growth-regulated
oncogene-alpha (GRO-alpha) and is involved in many
tumor types as an oncogene [48,49].
Differences between the regulation of clock genes in
humans versus rodents have been observed. Contrary to
the results in human adipose in this study, expression of
PER1 mRNA in rodents increased from the morning
through the evening [50]. In addition, the effect of fasting
and sibutramine in human adipose tissue was subtle;
again, quite different than in rodents, for which restricted
feeding produces profound effects on the peripheral clock
[51]. However, compared with the present study con-
ducted in overweight to mildly obese humans in the
course of one day, many of the rodent studies were con-
ducted in lean mice and the restricted feeding regimen
was conducted over many days, potentially confounding
the comparison between rodents and humans. Rhythmic
expression of clock genes is attenuated in the perigonadal
adipose tissues of obese KK mice and obese, diabetic KK-
Ay mice, indicating that obesity and disease state are intri-
cately linked to the circadian rhythm [6]. To further inves-
tigate the differences between rodent models and humans
and the association between obesity and circadian rhythm
in humans, a similar study in lean and morbidly obese
individuals could be conducted. Nevertheless, despite the
limitations noted, the major finding is that many genes in
the peripheral tissues, such as the adipose in both rodents
and humans, exhibit rhythmic expression. The circadian
output genes are also linked to metabolism in both spe-
cies and are affected by such stimuli as restricted feeding.
Rodent studies, examining white and brown adipose tis-
sue, liver and skeletal muscle, also showed the number of
genes under circadian regulation ranging from 3% to
26%, suggesting that a large proportion of the transcrip-
tome is under circadian control [5,10]. The estimation
from the current study is closer to the upper bound of
Table 3: Drugs with significant enrichment to diurnal signature 
in the Connectivity Map
rank drug mean n p-value
1 sirolimus 0.68 10 0
2 LY-294002 0.54 17 0
3 wortmannin 0.62 8 0.0001
4 trichostatin A 0.48 12 0.0012
5 resveratrol 0.61 5 0.0026
6 5182598 -0.78 2 0.0043
7 estradiol -0.39 10 0.0079
8 iloprost -0.71 3 0.0105
9 tacrolimus -0.56 3 0.0153
10 arachidonyltrifluoromethane -0.75 2 0.02
11 deferoxamine 0.49 3 0.0292
12 fludrocortisone -0.60 2 0.0429
13 quercetin -0.53 2 0.0607
14 TTNPB -0.57 2 0.0645
15 vorinostat 0.53 2 0.0734
16 fulvestrant 0.39 7 0.0858
17 raloxifene -0.15 3 0.0876
18 rottlerin 0.43 3 0.0945
The drugs with significant connectivity to the diurnal signature are 
ranked in the order of significance of the connectivity score as judged 
by the permutation p-value (column labeled "p-value"). Significance 
cut-off was set at pvalue = 0.1. The permutation p-value estimates the 
likelihood that the enrichment of a given set of post-dose gene 
expression changes (instances) by a given drug, relative to all available 
post-dose changes in the CMAP database (for all drugs) would be 
observed by random chance. Mean: the arithmetic mean of the 
connectivity scores for the post-dose changes by the given drug; N: 
the number of instances of a given drug in CMAP database[23].Page 13 of 16
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reflect the differences in the experimental designs and sta-
tistical power to detect changes. On the other hand, it
could be attributed to the dominant role of the adipose in
driving peripheral clocks in overweight individuals.
Clocks in peripheral tissues can be entrained by feeding
[52]. One can speculate that feeding patterns in humans
may play a substantial role in the synchronization of SCN-
controlled and food entrainable oscillations. This syn-
chronization may lead to more efficient energy utilization
by adipose and, in turn, may explain the effect of clock-
related genes, such as Nocturnin, on resistance to diet-
induced obesity [53]. Understanding cross-species simi-
larities and differences is necessary for a deeper under-
standing of how circadian rhythm affects physiology on
the whole.
Conclusion
To our knowledge, this is the first genome-wide gene
expression profiling study of clinical human adipose sam-
ples. The results offer new insights into the physiology of
adipose tissue in relation to the diurnal cycle, underscor-
ing the importance of diurnal rhythm for basic physiology
of the adipose tissue and energy metabolism in the body.
It provides a deeper understanding into the connection
between diurnal rhythm, energy metabolism, and growth
factor signaling. Consistent with previous reports, the
present findings suggest that the genes linked to PER1-led
oscillations may be exploited as novel points of interven-
tion for obesity and other metabolic phenotypes. A thor-
ough understanding of diurnal effects on energy
metabolism and the link to adipose physiology is impor-
tant for the selection of novel targets for the treatment of
obesity.
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Estimation of False Discovery Rate (FDR). Monte-Carlo simulation for 
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given p-value level vs. the alpha level as observed on the original (non-ran-
domized) data (red line) and the mean of 100 randomizations (blue 
line). Panel B depicts the estimated q-value vs. the p-value cut-off. Panel 
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of p-values up to 0.05 for all 4 panels.
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